Private company
Performant Healthcare Inc
American miscellaneous business services company, incorporated in Delaware1
In its 2025 annual report the company says: “We are a leading provider of these services in both government and commercial healthcare markets. We also provide advanced reporting capabilities, support services, customer care, and stakeholder training programs designed to mitigate future instances of improper payments. We endeavor to automate and optimize what traditionally have been manually intensive processes in order to drive higher workforce productivity.”4 It is headquartered in Plantation, Florida.1
Last updated Oct 20, 2026.
Overview
- IndustryServices-Miscellaneous Business Services1
- HeadquartersPlantation, Florida1
- Incorporated inDE2
- Business address900 South Pine Island Road, Suite 150, Plantation, Fl 333242
- Filer categoryAccelerated filer, Smaller reporting company2
See how the biggest companies compare on our leaderboards
We support payers in the healthcare industry with identifying, preventing, and recovering waste and improper payments by leveraging advanced technology, analytics and proprietary data assets. We work with leading national and regional healthcare payers to provide eligibility-based, also known as coordination-of-benefits (COB), services as well as claims-based services. Our eligibility based services involve identifying and recovering payments in situations where our client should not be the primary payer of healthcare claims because a member has other forms of insurance coverage, while our claims-based services include the audit and identification of improperly paid claims. We are a leading provider of these services in both government and commercial healthcare markets. We also provide advanced reporting capabilities, support services, customer care, and stakeholder training programs des…4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Other costs100¢$122.6M
- Income tax0¢$351.0K
Out of $123.0M in revenue.5 The company lost money this year.
Where each dollar of operating cash went, fiscal 2024
- Capital spending100¢$7.0M
Out of $6.2M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.5
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | $155.7M6 | $150.4M7 | $155.9M8 | $124.4M9 | $109.2M10 | $113.7M5 | $123.0M5 |
| Operating expenses | $125.7M9 | $116.1M10 | $119.9M5 | $132.5M5 | |||
| Operating income | -$1.8M6 | -$19.6M7 | -$14.0M8 | -$1.3M9 | -$6.9M10 | -$6.1M5 | -$9.5M5 |
| Interest | $4.7M6 | $7.6M7 | $7.2M8 | $11.3M9 | $1.0M10 | $2.0M10 | |
| Income before tax | -$10.2M9 | -$6.4M10 | -$7.9M5 | -$10.2M5 | |||
| Income tax | $1.5M6 | -$377.0K7 | -$7.2M8 | $62.0K9 | $132.0K10 | -$340.0K5 | -$351.0K5 |
| Net income | -$8.0M6 | -$26.8M7 | -$14.0M8 | -$10.3M9 | -$6.5M10 | -$7.5M5 | -$9.9M5 |
| Earnings per share | -$0.156 | -$0.507 | -$0.268 | -$0.179 | -$0.0910 | -$0.105 | -$0.135 |
| Earnings per share (diluted) | -$0.156 | -$0.507 | -$0.268 | -$0.179 | -$0.0910 | -$0.105 | -$0.135 |
| Shares (weighted, basic) | 60.5M shares9 | 72.9M shares10 | 76.2M shares5 | 77.5M shares5 | |||
| Shares (weighted, diluted) | 60.5M shares9 | 72.9M shares10 | 76.2M shares5 | 77.5M shares5 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Cash | $5.5M6 | $3.4M7 | $16.0M8 | $17.3M9 | $23.4M10 | $7.3M5 | $9.3M5 |
| Receivables | $20.8M9 | $15.8M10 | $17.6M5 | $14.2M5 | |||
| Current assets | $31.8M6 | $37.0M7 | $54.5M8 | $54.7M9 | $57.5M10 | $39.8M5 | $38.4M5 |
| Property, plant and equipment | $15.7M9 | $10.9M10 | $9.7M5 | $14.0M5 | |||
| Goodwill | $47.4M9 | $47.4M10 | $47.4M5 | $47.4M5 | |||
| Intangible assets | $08 | ||||||
| Total assets | $137.8M6 | $138.9M7 | $126.2M8 | $122.0M9 | $118.8M10 | $99.0M5 | $101.8M5 |
| Accounts payable | $1.1M9 | $1.3M10 | $727.0K5 | $482.0K5 | |||
| Short-term debt | $489.0K9 | $983.0K10 | $010 | ||||
| Current liabilities | $14.1M6 | $19.4M7 | $77.2M8 | $17.5M9 | $14.2M10 | $12.4M5 | $14.0M5 |
| Long-term debt | $41.1M13 | $58.6M6 | $08 | $19.1M9 | $18.2M10 | $010 | |
| Total liabilities | $60.5M6 | $85.2M7 | $84.2M8 | $39.6M9 | $34.3M10 | $18.3M5 | $25.3M5 |
| Retained earnings | -$51.2M9 | -$57.8M10 | -$65.3M5 | -$75.2M5 | |||
| Shareholders’ equity | $77.2M7 | $53.6M8 | $42.0M8 | $82.4M9 | $84.5M10 | $80.7M5 | $76.5M5 |
| Shares outstanding | 53.0M shares6 | 53.9M shares7 | 54.8M shares8 | 69.3M shares9 | 75.5M shares10 | 76.9M shares5 | 78.3M shares5 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -$12.1M6 | -$15.4M7 | $20.8M8 | $916.0K9 | -$2.9M10 | $3.9M5 | $6.2M5 |
| Depreciation and amortization | $5.2M9 | $4.5M10 | $5.2M5 | $6.6M5 | |||
| Stock-based compensation | $2.6M9 | $3.0M10 | $3.9M5 | $5.9M5 | |||
| Capital spending | $7.6M6 | $4.9M7 | $3.8M8 | $3.4M9 | $3.6M10 | $4.1M5 | $7.0M5 |
| Free cash flow | -$19.8M | -$20.3M | $17.0M | -$2.5M | -$6.5M | -$283.0K | -$832.0K |
| Cash from investing | -$270.0K9 | $1.7M10 | -$4.1M5 | -$7.0M5 | |||
| Dividends paid | |||||||
| Share buybacks | |||||||
| Cash from financing | $608.0K9 | $5.1M10 | -$15.9M5 | $2.8M5 |
Corporate structure
Performant Healthcare Inc sits at the top of its group. 4 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Performant Healthcare Inc
- Topline Capital Management, LLC Filed SCHEDULE 13G/A on Performant Healthcare Inc, latest Nov 14, 2025 (3 filings since Apr 18, 2024)
- GLAZER CAPITAL, LLC Filed SCHEDULE 13G/A on Performant Healthcare Inc, latest Nov 13, 2025 (2 filings since Aug 21, 2025)
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on Performant Healthcare Inc, latest Oct 30, 2025 (2 filings since Jul 29, 2025)
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Filed SCHEDULE 13D/A on Performant Healthcare Inc, latest Oct 23, 2025 (5 filings since Oct 7, 2021)
- First Light Asset Management, LLC Filed SCHEDULE 13G/A on Performant Healthcare Inc, latest Aug 14, 2025 (5 filings since Feb 14, 2022)
- PARTHENON INVESTORS II. L.P. Filed SC 13G/A on Performant Healthcare Inc, latest Feb 8, 2024 (3 filings since Feb 8, 2022)
- ECMC Group, Inc. Filed SC 13G/A on Performant Healthcare Inc, latest Feb 14, 2023 (2 filings since Feb 7, 2022)
- Mill Road Capital II, L.P. Filed SC 13D/A on Performant Healthcare Inc, latest Aug 31, 2022
- Performant Healthcare Inc Plantation, Florida
- Performant Business Services, Inc. Subsidiary · Nevada, United States
- Performant Recovery, Inc. Subsidiary · California, United States
- Performant Technologies, LLC. Subsidiary · California, United States
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Performant Healthcare Inc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $61.9M5 Dec 31, 2024 | $74.3M5 Dec 31, 2023 | −16.7% |
| Accumulated depreciation | $47.9M5 Dec 31, 2024 | $64.6M5 Dec 31, 2023 | −25.9% |
| Property and equipment, net | $14.0M5 Dec 31, 2024 | $9.7M5 Dec 31, 2023 | +44.2% |
| Operating-lease assets (leased space) | $826.0K5 Dec 31, 2024 | $531.0K5 Dec 31, 2023 | +55.6% |
Investments
Intangibles and goodwill
Properties, in its own words
Facilities
As of December 31, 2024, we operated four separate office locations throughout the United States. Our Plantation, Florida facility serves as our corporate headquarters.
The rest of Item 2
We believe that our facilities are adequate for current operations and that additional space will be available as required. See Note 4 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for information regarding our lease obligations.
Item 2 of the 10-K filed Mar 13, 2025.4
Leadership
Who has led Performant Healthcare Inc, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerSimeon Kohl May 9, 2023 to now14
- Chief executive officerLisa Im Aug 9, 2012 to Jan 16, 201815
- PresidentSimeon Kohl May 17, 2022 to Aug 16, 202216
- PresidentJeffrey Haughton Aug 21, 2015 to Aug 21, 201517
- Chief financial officerRohit Ramchandani May 9, 2023 to now18
- Chief financial officerHakan Orvell Aug 9, 2012 to Apr 10, 201719
- Chief operating officerJeffrey Haughton Apr 14, 2016 to Nov 1, 201720
- Chief operating officerHarold Leach Jr. Aug 9, 2012 to Mar 18, 201621
Board members and other officers (20)
- OfficerIan Johnston Apr 17, 2017 to Sep 11, 202322
- Vice President of HealthcareSimeon Kohl Apr 17, 2017 to Mar 14, 202223
- Executive Vice PresidentJeffrey Haughton Feb 25, 2016 to Jul 17, 201824
- Chief Compliance OfficerHarold Leach Jr. Aug 16, 2016 to Aug 17, 202125
- SVP of Corporate ServicesBruce Calvin Aug 9, 2012 to Apr 25, 201326
- SVP of Sales and MarketingJohn Paik Aug 9, 2012 to Aug 7, 201427
- OfficerJon Shaver Aug 9, 2012 to Jan 13, 201428
- Board memberShantanu Agrawal Mar 7, 2024 to now29
- Board memberSimeon Kohl May 9, 2023 to now14
- Board memberEric Yanagi May 7, 2020 to now30
- Board memberJames Lacamp Nov 20, 2019 to now31
- Board memberFluegel M. Bradley Feb 6, 2014 to now32
- Board memberBruce Edward Hansen Apr 15, 2013 to Jun 25, 201833
- Board memberBrian P. Golson Aug 9, 2012 to Sep 10, 201434
- Board memberJeffrey S. Stein Aug 9, 2012 to Nov 27, 201335
- Board memberJon Shaver Aug 9, 2012 to Jan 13, 201428
- Board memberLisa Im Aug 9, 2012 to now15
- Board memberTodd R. Ford Aug 9, 2012 to Jun 25, 201836
- Board memberWilliam C. Kessinger Aug 9, 2012 to Nov 27, 201337
- Board memberWilliam Dean Hansen Aug 9, 2012 to now38
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Performant Business Services, Inc. Nevada3
- Performant Recovery, Inc. California3
- Performant Technologies, LLC. California3
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- Performant Financial CorpJun 18, 2012 to Nov 15, 20242
Timeline
- Oct 21, 20258-K Ended a material agreement; Completed an acquisition or sale; Listing notice or transfer39
- Oct 17, 20258-K Shareholder vote40
- Aug 1, 20258-K Entered a material agreement; Executive or director change41
- Aug 1, 20258-K Results of operations42
- Jun 23, 20258-K Shareholder vote43
- May 8, 20258-K Results of operations44
- Mar 12, 20258-K Results of operations45
- Dec 10, 20248-K Bylaws or fiscal year changed46
- Nov 6, 20248-K Results of operations47
- Aug 7, 20248-K Results of operations48
- Jun 24, 20248-K Shareholder vote49
- May 7, 20248-K Results of operations50
- May 9, 2023New chief executive Simeon Kohl becomes CEO14
- Aug 9, 2012New chief executive Lisa Im becomes CEO15
Calendar
When it reported results
- Aug 1, 2025Reported quarterly or annual results42
- May 8, 2025Reported quarterly or annual results44
- Mar 12, 2025Reported quarterly or annual results45
- Nov 6, 2024Reported quarterly or annual results47
- Aug 7, 2024Reported quarterly or annual results48
- May 7, 2024Reported quarterly or annual results50
- Mar 12, 2024Reported quarterly or annual results51
- Nov 7, 2023Reported quarterly or annual results52
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
180 filings to the SEC since October 2021: 4 annual reports, 12 quarterly reports, 30 major events, 82 insider forms, 23 large holders, 29 other. The latest 20:
- Nov 20, 2025EFFECT EDGAR
- Nov 14, 2025SCHEDULE 13G/A EDGAR
- Nov 13, 2025SCHEDULE 13G/A EDGAR
- Oct 31, 202515-12G EDGAR
- Oct 30, 2025SCHEDULE 13G/A EDGAR
- Oct 23, 2025SCHEDULE 13D/A EDGAR
- Oct 22, 20254 EDGAR
- Oct 21, 20254 EDGAR
- Oct 21, 20254 EDGAR
- Oct 21, 20254 EDGAR
- Oct 21, 20254 EDGAR
- Oct 21, 20254 EDGAR
- Oct 21, 20254 EDGAR
- Oct 21, 20254 EDGAR
- Oct 21, 2025POS AM EDGAR
- Oct 21, 2025S-8 POS EDGAR
- Oct 21, 2025S-8 POS EDGAR
- Oct 21, 2025S-8 POS EDGAR
- Oct 21, 2025S-8 POS EDGAR
- Oct 21, 20258-K EDGAR
The 180 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
30 open-market trades by officers, directors and large owners since October 2021: 18 buys and 12 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 3, 2025 | Im LisaDirector | Sale | 180,867 | $3.25 | $587.8K | Form 4 |
| Dec 10, 2024 | Im LisaDirector | Sale | 6,154 | $3.26 | $20.1K | Form 4 |
| May 10, 2023 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10% owner | Buy | 30,000 | $2.61 | $78.3K | Form 4 |
| Mar 17, 2023 | PRESCOTT GROUP AGGRESSIVE SMALL CAP II LP10% owner | Buy | 300,182 | $2.66 | $798.5K | Form 4 |
| Mar 16, 2023 | PRESCOTT GROUP AGGRESSIVE SMALL CAP II LP10% owner | Buy | 2,770 | $2.80 | $7.8K | Form 4 |
| Mar 15, 2023 | PRESCOTT GROUP AGGRESSIVE SMALL CAP II LP10% owner | Buy | 5,635 | $2.85 | $16.1K | Form 4 |
| Mar 25, 2022 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10% owner | Buy | 100,000 | $2.84 | $284.0K | Form 4 |
| Mar 16, 2022 | ECMC Group, Inc.10% owner | Sale | 194,334 | $2.27 | $441.1K | Form 4 |
| Mar 7, 2022 | ECMC Group, Inc.10% owner | Sale | 24,229 | $2.00 | $48.5K | Form 4 |
| Mar 4, 2022 | ECMC Group, Inc.10% owner | Sale | 17,219 | $2.01 | $34.6K | Form 4 |
| Mar 3, 2022 | ECMC Group, Inc.10% owner | Sale | 22,434 | $2.06 | $46.2K | Form 4 |
| Mar 2, 2022 | ECMC Group, Inc.10% owner | Sale | 52,650 | $2.19 | $115.3K | Form 4 |
| Mar 1, 2022 | ECMC Group, Inc.10% owner | Sale | 27,425 | $2.12 | $58.1K | Form 4 |
| Feb 28, 2022 | ECMC Group, Inc.10% owner | Sale | 26,662 | $2.32 | $61.9K | Form 4 |
| Feb 25, 2022 | ECMC Group, Inc.10% owner | Sale | 16,500 | $2.25 | $37.1K | Form 4 |
| Feb 24, 2022 | ECMC Group, Inc.10% owner | Sale | 39,072 | $2.19 | $85.6K | Form 4 |
| Feb 23, 2022 | ECMC Group, Inc.10% owner | Sale | 20,000 | $2.32 | $46.4K | Form 4 |
| Jan 28, 2022 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10% owner | Buy | 168,210 | $1.89 | $317.9K | Form 4 |
| Jan 27, 2022 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10% owner | Buy | 115,025 | $1.91 | $219.7K | Form 4 |
| Jan 24, 2022 | PRESCOTT GROUP AGGRESSIVE SMALL CAP II LP10% owner | Buy | 444,685 | $1.96 | $871.6K | Form 4 |
All 30 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Topline Capital Management, LLCSCHEDULE 13G/A, 3 filings Apr 18, 2024 to Nov 14, 202553
- GLAZER CAPITAL, LLCSCHEDULE 13G/A, 2 filings Aug 21, 2025 to Nov 13, 202554
- VANGUARD GROUP INCSCHEDULE 13G/A, 2 filings Jul 29, 2025 to Oct 30, 202555
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.SCHEDULE 13D/A, 5 filings Oct 7, 2021 to Oct 23, 202556
- First Light Asset Management, LLCSCHEDULE 13G/A, 5 filings Feb 14, 2022 to Aug 14, 202557
- PARTHENON INVESTORS II. L.P.SC 13G/A, 3 filings Feb 8, 2022 to Feb 8, 202458
- ECMC Group, Inc.SC 13G/A, 2 filings Feb 7, 2022 to Feb 14, 202359
- Mill Road Capital II, L.P.SC 13D/A, 1 filing Aug 31, 202260
SEC filer profile
How Performant Healthcare Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARPerformant Healthcare Inc1
- CIK0001550695
- Employer ID (EIN)20-04849344
- Filer statusAccelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
- Incorporated inDelaware4
- Fiscal year endsDecember 311
- Industry code (SIC)7380 Services-Miscellaneous Business Services1
- SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
- Business address900 South Pine Island Road, Suite 150, Plantation, FL 333241
- Mailing address4309 Hacienda Dr, Suite 110, Pleasanton, CA 945881
- Phone925-960-48001
- Shares outstanding78,997,024 as of Aug 6, 202512
- Public float$127.8M as of Jun 30, 20244
- AuditorBaker Tilly US, LLP, Atlanta, Georgia PCAOB ID 23; it also attests to the company’s internal control over financial reporting4
- On EDGAR sinceJun 18, 20121
- Filings696 in all: 4 (321), 8-K (114), 10-Q (39), SC 13G/A (36), 3 (25), CORRESP (14), DEFA14A (14), UPLOAD (14)1
All 39 form types
10-K (13), DEF 14A (13), SC 13G (13), SC 13D/A (10), EFFECT (9), S-1/A (8), S-3 (5), 424B5 (4), S-8 (4), S-8 POS (4), SC 13D (4), SCHEDULE 13G/A (4), 424B4 (3), S-1 (3), 10-K/A (2), 144 (2), PRE 14A (2), SCHEDULE 13D/A (2), SCHEDULE 13G (2), 15-12G (1), 25-NSE/A (1), 4/A (1), 8-A12B (1), 8-K/A (1), CERTNAS (1), DEFM14A (1), DEFR14A (1), NT 10-K (1), POS AM (1), PREM14A (1), S-1MEF (1)
- Latest filingsAnnual report (10-K) Mar 13, 2025
Quarterly report (10-Q) Aug 7, 2025
Proxy statement (DEF 14A) Aug 5, 2025
Latest 8-K (8-K) Oct 21, 2025
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $.0001 per share | PHLT | Nasdaq |
From the cover page of the 10-K filed Mar 13, 2025 (Section 12(b) of the Exchange Act).4
Risk factors and legal proceedings
The risks Performant Healthcare Inc names in Item 1A of its 10-K filed Mar 13, 2025: 29 risks under these headings, as written.4
- Risks Related to Our Business
- We typically face a long period to start up a new contract which may cause us to incur expenses before we receive revenues from new clients or new contract relationships.
- Revenues generated from a limited number of our largest clients represent a substantial majority of our revenues. Any termination of or deterioration in our relationship with any of our significant clients would result in a decline in our revenues.
- Many of our contracts with our clients are not exclusive and do not commit our clients to provide specified volumes of business. In addition, the terms of these contracts may be changed unilaterally and on short notice by our clients. As a consequence, there is no assurance that we will be able to maintain our revenues and operating results.
- We face significant competition in connection with obtaining, retaining and performing under our client contracts, and an inability to compete effectively in the future could harm our relationships with our clients, which would impact our ability to maintain our revenues and operating results.
- Our ability to derive revenues under our current healthcare contracts will depend in part on the number and types of potentially improper claims that we are allowed to audit or otherwise pursue by our clients, and our results of operations may be harmed if the scope of claims that we are allowed to pursue and be compensated for is limited.
- Our indebtedness could adversely affect our business and financial condition and reduce the funds available to us for other purposes, and our failure to comply with the covenants contained in our Credit Agreement could result in an event of default that could adversely affect our results of operations.
- The U.S. federal government accounts for a significant portion of our revenues, and any loss of business from, or change in our relationship with the U.S. federal government would result in a significant decrease in our revenues and operating results.
- We may not be able to manage our potential growth effectively and our results of operations could be negatively affected.
- The growth of our healthcare business will require us to hire and retain employees with specialized skills and failure to do so could harm our ability to grow our business.
- Downturns in domestic or global economic conditions and other macroeconomic factors could harm our business and results of operations.
- We may not have sufficient cash flows from operations or availability of funds under our lending arrangements to fund our ongoing operations and our other liquidity needs, which could adversely affect our business and financial condition.
The other 18 risks
- Public health emergencies such as the novel coronavirus (COVID-19) pandemic have adversely affected and could adversely affect our business, results of operations and financial condition.
- Our results of operations may fluctuate on a quarterly or annual basis and cause volatility in the price of our stock.
- Risks Related to Information Technology, Privacy Matters, and Intellectual Property
- A failure of our operating systems or technology infrastructure, or those of our third-party vendors, service providers or subcontractors, could disrupt the operation of our business.
- If our security measures are breached or fail and unauthorized access is obtained to our clients’ confidential data, our services may be perceived as insecure, the attractiveness of our services to current or potential clients may be reduced, and we may incur significant liabilities.
- If our software vendors or utility and network providers fail to deliver or perform as expected our business operations could be adversely affected.
- Increasing use of social media and new technology, including artificial intelligence software, could give rise to liability, breaches of data security, or reputational damage.
- If we are unable to adequately protect our proprietary technology, our competitive position could be harmed, or we could be required to incur significant costs to enforce our rights.
- Claims by others that we infringe their intellectual property could force us to incur significant costs or revise the way we conduct our business.
- Risks Related to Regulations and Legislation
- We identified a material weakness in our internal control over financial reporting in the fourth quarter of 2022. If we experience additional material weaknesses or other deficiencies, or if we are unable to remediate material weaknesses or other deficiencies identified in the future, or otherwise fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately or timely report our financial results, which could result in loss of investor confidence and adversely impact our stock price.
- Future legislative or regulatory changes affecting the markets in which we operate could impair our business and operations.
- We are subject to extensive regulations regarding the use and disclosure of confidential personal information and failure to comply with these regulations could cause us to incur liabilities and expenses.
- Our legacy student loan recovery business is subject to extensive regulation and consumer protection laws and our failure to comply with these regulations and laws may subject us to liability and result in significant costs.
- Risks Related to our Common Stock
- The price of our common stock could be volatile, and you may not be able to sell your shares at or above the public offering price.
- Our significant stockholders have the ability to influence significant corporate activities and our significant stockholders' interests may not coincide with yours.
- General Risks
- We may undertake strategic transactions or other corporate restructuring that prove unsuccessful, strain or divert our resources and harm our results of operations and stock price.
- Litigation may result in substantial costs of defense, damages or settlement, any of which could subject us to significant costs and expenses.
- Our business may be harmed if we lose members of our management team or other key employees.
- Anti-takeover provisions contained in our certificate of incorporation and bylaws could impair a takeover attempt that our stockholders may find beneficial.
Legal proceedings
We are involved in various legal proceedings that arise from our normal business operations from time to time. The outcome of any such legal proceedings, regardless of the merits, is inherently unpredictable. Legal proceedings, including litigation, government investigations and enforcement actions, can result in significant costs and occupy significant management resources. We do not expect any such current legal proceedings to have a material adverse impact on our business or financial condition.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARSimeon Kohl, Chief executive officer
- 15SEC EDGARLisa Im, Chief executive officer
- 16SEC EDGARSimeon Kohl, President
- 17SEC EDGARJeffrey Haughton, President
- 18
- 19
- 20
- 21
- 22SEC EDGARIan Johnston, Officer
- 23
- 24
- 25
- 26
- 27
- 28SEC EDGARJon Shaver, Officer
- 29SEC EDGARShantanu Agrawal, Board member
- 30SEC EDGAREric Yanagi, Board member
- 31SEC EDGARJames Lacamp, Board member
- 32SEC EDGARFluegel M. Bradley, Board member
- 33SEC EDGARBruce Edward Hansen, Board member
- 34SEC EDGARBrian P. Golson, Board member
- 35SEC EDGARJeffrey S. Stein, Board member
- 36SEC EDGARTodd R. Ford, Board member
- 37SEC EDGARWilliam C. Kessinger, Board member
- 38SEC EDGARWilliam Dean Hansen, Board member
- 39
- 40SEC EDGARShareholder vote
- 41
- 42SEC EDGARResults of operations
- 43SEC EDGARShareholder vote
- 44SEC EDGARResults of operations
- 45SEC EDGARResults of operations
- 46SEC EDGARBylaws or fiscal year changed
- 47SEC EDGARResults of operations
- 48SEC EDGARResults of operations
- 49SEC EDGARShareholder vote
- 50SEC EDGARResults of operations
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60